By Amina Niasse NEW YORK (Reuters) -UnitedHealth Group investors, stunned by missteps at the once predictable healthcare ...

UnitedHealth's challenges are manageable, leadership changes boost confidence, and long-term growth shows promise with 15% ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The Wall Street Journal on Wednesday cited people familiar with the matter as saying that the probe has been ongoing since ...

UnitedHealth Group is facing new scrutiny after The Wall Street Journal reported that the Department of Justice is investigating the company for potential criminal healthcare fraud ...

Insurance giant UnitedHealth Group is facing a criminal investigation by the US Justice Department for possible Medicare ...

The U.S. Department of Justice (DOJ) is carrying out a criminal investigation into UnitedHealth Group for possible Medicare ...

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.

UnitedHealth Group chief executive Andrew Witty stepped down suddenly today, the company said, as it suspended its 2025 ...

UnitedHealth Group is being investigated by the U.S. Department of Justice (DOJ) for criminal fraud in the Medicare program.

UnitedHealth said in a statement late Wednesday that the Department of Justice hadn’t notified the company about the reported ...

Shares of UnitedHealth Group tumbled 16% in intraday trading Thursday, leading S&P 500 decliners, on a report that the U.S.